Yes, Alzheimer’s disease is the most common form of dementia by a wide margin. It accounts for 60% to 80% of all dementia cases, making it far more prevalent than any other type. Globally, about 57 million people were living with dementia as of 2021, and the majority of those cases involved Alzheimer’s.
How Alzheimer’s Compares to Other Types
Dementia is an umbrella term for a decline in thinking, memory, and reasoning severe enough to interfere with daily life. Alzheimer’s is the single largest cause, but it’s not the only one. The ranking, by prevalence, looks roughly like this:
- Alzheimer’s disease: 60% to 80% of cases
- Vascular dementia: the second most common type, caused by reduced blood flow to the brain (often after strokes or small vessel disease)
- Lewy body dementia: accounts for roughly 10% to 15% of autopsy-confirmed cases, making it one of the most common neurodegenerative causes after Alzheimer’s and vascular dementia
- Frontotemporal dementia: less common overall but disproportionately affects younger adults, typically appearing between ages 45 and 65
These categories aren’t as neat as they appear on paper. At autopsy, many people turn out to have more than one type of brain pathology happening simultaneously. A major study of adults over 90 found that 45% of those with dementia had mixed pathologies, meaning two or more types of damage were present in the brain at the same time. This was true for nearly half of people with dementia but only 14% of those without it. So while Alzheimer’s dominates the statistics, it frequently overlaps with vascular changes or Lewy body pathology, especially in older adults.
What Makes Alzheimer’s Different Biologically
Each type of dementia damages the brain in a distinct way. In Alzheimer’s, two abnormal proteins are the central culprits. The first is beta-amyloid, a fragment of a larger protein that clumps together between brain cells and forms sticky plaques. The beta-amyloid 42 form is considered especially toxic. The second is tau, a protein that normally helps stabilize the internal structure of neurons. In Alzheimer’s, tau molecules detach, stick to each other, and form tangles inside nerve cells that disrupt their ability to function and communicate.
This combination of plaques outside cells and tangles inside them is the hallmark of Alzheimer’s and what distinguishes it from other dementias at the tissue level. Vascular dementia, by contrast, results from damage to blood vessels in the brain. Lewy body dementia involves clumps of a different protein (alpha-synuclein) that form inside neurons. Frontotemporal dementia involves degeneration in the frontal and temporal lobes, often driven by abnormal tau or other proteins, but in a different pattern than Alzheimer’s.
How Symptoms Differ Across Types
Alzheimer’s typically starts with memory loss, particularly difficulty forming new memories. You might forget recent conversations, repeat questions, or lose track of appointments. This early, prominent memory impairment is one of the key features that helps clinicians distinguish Alzheimer’s from other forms.
Lewy body dementia follows a different pattern. Memory problems tend to appear later in the disease. Instead, early symptoms often include visual hallucinations, fluctuating alertness, and movement difficulties similar to Parkinson’s disease. People with Lewy body dementia may also show diminished emotional responsiveness, loss of interest in hobbies, and increased apathy.
Vascular dementia often looks different again. Rather than a gradual slide, it can progress in noticeable steps, especially if it’s triggered by a series of small strokes. People with vascular dementia tend to have more trouble with planning, organizing, and problem-solving early on, while memory may be relatively preserved at first. Neuropsychological testing generally shows more difficulty generating words and maintaining focus compared to Alzheimer’s patients.
Frontotemporal dementia is perhaps the most dramatically different. It often begins with personality changes, impulsive behavior, or loss of social awareness rather than memory problems. Some people develop language difficulties as the primary symptom, struggling to find words or understand them.
Who Gets Alzheimer’s
Age is the strongest risk factor. The vast majority of Alzheimer’s cases occur in people over 65, and the risk roughly doubles every five years after that. But it also affects people unevenly across demographics. Women are about twice as likely to develop Alzheimer’s as men, a gap that scientists still can’t fully explain. Part of it may be that women live longer on average, giving the disease more time to develop, but longevity alone doesn’t account for the entire difference. Hormonal, genetic, and immune factors are all being investigated.
More than 60% of people living with dementia worldwide are in low- and middle-income countries, where access to diagnosis and support is often limited. This means the global burden of Alzheimer’s falls hardest on populations with the fewest resources to manage it.
Why Mixed Dementia Complicates the Picture
The clean percentages cited for each dementia type are useful but somewhat misleading. In real brains, especially older ones, pathologies overlap. A person diagnosed with Alzheimer’s during their lifetime may also have significant vascular damage or Lewy body changes discovered after death. Research on the oldest-old has shown that dementia in this group is generally associated with mixed rather than single brain pathologies.
This matters for a practical reason: it helps explain why two people with the same Alzheimer’s diagnosis can have very different symptoms, rates of decline, and responses to treatment. If someone’s cognitive decline is driven partly by Alzheimer’s plaques and partly by vascular damage from small strokes, their experience will differ from someone with pure Alzheimer’s pathology. Clinicians now increasingly recognize that a single label rarely tells the whole story, particularly in people over 80.